A groundbreaking tool designed to improve the management of high blood pressure could soon change how doctors prescribe medications for hypertension.
Researchers have developed the Blood Pressure Treatment Efficacy Calculator, the first evidence-based tool of its kind. Drawing on data from nearly 500 randomized clinical trials and more than 100,000 patients, the calculator allows clinicians to estimate how much different medications—and their combinations—are likely to lower blood pressure. The findings were published today in The Lancet.
Addressing Complexity in Treatment
Hypertension is the leading reason people visit their doctors, yet treatment decisions often involve trial and error. With dozens of available medications, multiple dosage options, and most patients requiring two or more drugs, clinicians face thousands of possible treatment pathways. Until now, there has been no single, comprehensive resource to help predict outcomes.
“This tool helps solve that problem by calculating the average effect of treatments across hundreds of trials,” said Dr. Xuejun Wang, one of the study authors. “It categorizes therapies into low-, moderate-, and high-intensity groups, similar to how cholesterol-lowering treatments are classified.”
On average, a single antihypertensive medication lowers systolic blood pressure by only 8–9 mmHg. However, most patients need a reduction of 15–30 mmHg to reach guideline-recommended targets.
Overcoming the Limitations of Traditional Methods
Currently, treatment decisions are often guided by repeated blood pressure measurements. But as Dr. Wang explained, readings can be highly variable and unreliable.
“Blood pressure changes from moment to moment, day to day, and even season to season,” he said. “These random fluctuations can be as large—or larger—than the changes brought about by medication. In addition, imperfect measurement practices introduce more uncertainty, making it very difficult to assess treatment effectiveness using readings alone.”
Anthony Rodgers, Senior Professorial Fellow at The George Institute for Global Health, said the calculator challenges the conventional “start low, go slow, measure and judge” approach.
“That method often leads to delays, inertia, and treatment burdens on patients,” Rodgers said. “With this calculator, doctors can determine the reduction needed, select an evidence-based treatment plan to meet that goal, and start therapy earlier.”
Next Steps and Global Health Impact
The research team plans to test the tool in clinical trials, where patients’ treatments will be tailored to their blood pressure reduction needs as predicted by the calculator.
The potential impact is significant. Hypertension affects an estimated 1.3 billion people worldwide and contributes to around 10 million deaths annually. Often referred to as a “silent killer,” the condition typically causes no symptoms until it leads to serious complications such as stroke, heart attack, or kidney disease. Alarmingly, fewer than 20% of people with hypertension have it under control.
“Even modest improvements in hypertension control could save millions of lives,” Rodgers emphasized. “If we could increase global treatment success to just 50%, the public health benefits would be enormous.”
